Home

JOHN P. SAHAREK

CIK 1632091 · CEO & President, ImprimisRx · last filed 2025-04-07

JOHN P. SAHAREK is a CEO & President, ImprimisRx who has filed 16 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for HROWM, was dated Apr 7, 2025. 17 SEC filings were submitted jointly with HARROW HEALTH, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

16

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
12264 EL CAMINO REAL
SUITE 350
SAN DIEGO, CA 92130
Related Filers
HARROW HEALTH, INC. — 17 joint filings, latest 2025-04-07
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HARROW, INC. (HROWM) Delisted CEO & President, ImprimisRx 576,863 $26.03 $15.02M $0 7 2025-04-07
HARROW, INC. (HROWL) Delisted President, ImprimisRx 80,000 $25.61 $2.05M $0 2 2022-02-23
HROW President, ImprimisRx — $33.07 — $0 2 2021-02-23
HARROW, INC. (IMMY) Delisted Chief Commercial Officer 30,000 — — $0 5 2018-02-02

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-04-07 HARROW, INC. (HROWM) Delisted Mixed +167,725 -$2.53M EDGAR
2024-09-13 HARROW, INC. (HROWM) Delisted Mixed +44,860 -$1.20M EDGAR
2024-03-06 HARROW, INC. (HROWM) Delisted Exer (M) +5,000 $43.8K EDGAR
2024-02-21 HARROW, INC. (HROWM) Delisted Exer (M) +17,384 $185.5K EDGAR
2023-11-14 HARROW, INC. (HROWM) Delisted Mixed +10,222 -$125.5K EDGAR
2023-07-20 HARROW, INC. (HROWM) Delisted Mixed +168,120 -$1.99M EDGAR
2023-04-04 HARROW, INC. (HROWM) Delisted Grant (A) — $0 EDGAR
2022-02-23 HARROW, INC. (HROWL) Delisted Mixed +24,077 -$204.0K EDGAR
2021-07-23 HARROW, INC. (HROWL) Delisted Grant (A) — $0 EDGAR
2021-02-23 HROW Grant (A) — $0 EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.